Podcast Episodes
Back to Search
Episode 356: #UromigosLive24 - Front-line Therapy in Papillary and Non-clear Cell RCC
Brian moderates the panel that discusses and debates TKI, vs Ipi/Nivo vs IO/TKI
2 years, 1 month ago
Episode 355: #UromigosLive24 - Radioligands in prostate cancer
The Uromigos Live 2024 panel discusses recent radioligand data including PEACE-3
2 years, 1 month ago
Episode 354: #UromigosLive24 - T cell directed therapy in prostate cancer
Brian hosts a panel at Uromigos Live 2024 in Nashville with Michael Morris, Tanya Dorff and Karen Autio
2 years, 1 month ago
Episode 353: #UromigosLive24 ADC session
Tom moderates a live panel of Kala Sridhar, Shilpa Gupta, Andrea Apolo and Petros Grivas on the emerging ADC data in bladder cancer
2 years, 1 month ago
Episode 352: ESMO 2024 - RCC and Bladder review
Tom and Brian finish discussing ESMO 2024 highlights. Even without a guest Tom still interrupts a lot.
2 years, 1 month ago
Episode 351: ESMO 2024 review part 1: prostate cancer
Silke joins us to discuss ESMO 2024 highlights, then the birds start singing....
2 years, 1 month ago
Episode 350: ESMO 2024 - NIAGARA
Fresh of the Presidential session address, Tom discusses his data with Petros commenting.
2 years, 1 month ago
Episode 349: ESMO 2024 - Uromigos Japan!!
Uromigos Japan with Yuji, Hiroshi and Nobu is formed and discuss Hiroshi's ESMO data.
2 years, 1 month ago
Episode 348: ESMO 2024 - UpFrontPSMA
Arun Azad describes this randomised phase II study of sequential 177Lu-PSMA-617 and docetaxel vs. docetaxel in mHSPC
2 years, 1 month ago
Episode 347: ESMO 2024 - DV + Pembro in Urothelial Cancer
Matt Galsky describes his ESMO 2024 abstract of disitimab vedotiin + pembrlizumab in bladder cancer
2 years, 1 month ago